Daily Insights
S&P 500 Index opens near flat. Positive vaccine news sent the S&P 500 higher Monday, but the market seems to be pausing this morning.
- The S&P 500 Index finished a solid 1.2% higher on Monday, hitting its highest level in two months on positive vaccine news.
- Strong rotation toward small-cap stocks and value-style stocks signaled the type of impact further vaccine progress may have on markets.
- Despite the solid day, the S&P 500 was well off its initial move higher.
- The MSCI Asia Pacific closed 0.4% higher, with the impact of vaccine progress diminishing overseas.
- The Stoxx Europe 600 traded modestly higher at midday.
- The ZEW survey, a key measure of German investor sentiment, showed waning confidence in the German economy amid rising COVID-19 cases.
Vaccine news. Positive vaccine news has continued to act as a catalyst for markets this year, but there still may be operational challenges around production and distribution. Monday’s move was a positive signal, but the market seemed to be pausing this morning as market participants further digested yesterday’s optimistic news.
Bonds shift away from the post-election story. The 10-year Treasury yield fell sharply post-election as the market started to price in a divided government and a potentially weaker stimulus bill. But positive vaccine news Monday reminded us the election isn’t the only story. The 10-year yield bounced sharply higher Monday, finishing at its highest level since March. Today’s LPL Research blog covers more on the bond market’s post-election reaction.
Veterans Day is Nov. 11. November 11 is Veterans Day and a Federal holiday. Collaborative Wealth, LPL Financial, and the stock and bond markets will be open. Some banks may be closed.
Technical update. Year-to-date laggards rallied Monday, while mega-cap growth names lagged significantly. The S&P 500 set a new intraday record, at one point up as much as 3.9%, before closing more than 2.6% off its highs and failing to set a record closing high. Breadth was mediocre given the early gains, as advancers on the NYSE outnumbered decliners by just over 3:1. Value outperformed growth by 5.7%, the most in the history of the Russell 1000 Growth and Value indexes.
COVID-19 news. The surge in COVID-19 cases in the United States continued on Monday, rising 43% week over week, pushing the seven-day average up to 112,000, a 35% week-over-week increase (source: COVID Tracking Project). Hospitalizations rose 53% week over week, or 34% based on the seven-day average. The FDA approved Eli Lilly’s COVID-19 therapeutic for emergency use in mild cases, adding to this week’s string of good news on treatments.
IMPORTANT DISCLOSURES
This material is for general information only and is not intended to provide specific advice or recommendations for any individual. There is no assurance that the views or strategies discussed are suitable for all investors or will yield positive outcomes. Investing involves risks including possible loss of principal. Any economic forecasts set forth may not develop as predicted and are subject to change.
References to markets, asset classes, and sectors are generally regarding the corresponding market index. Indexes are unmanaged statistical composites and cannot be invested into directly. Index performance is not indicative of the performance of any investment and do not reflect fees, expenses, or sales charges. All performance referenced is historical and is no guarantee of future results.
Any company names noted herein are for educational purposes only and not an indication of trading intent or a solicitation of their products or services. LPL Financial doesn’t provide research on individual equities.
All information is believed to be from reliable sources; however, LPL Financial makes no representation as to its completeness or accuracy.
All index and market data are from FactSet and MarketWatch.
This Research material was prepared by LPL Financial, LLC.
Securities and advisory services offered through LPL Financial (LPL), a registered investment advisor and broker-dealer (member FINRA/SIPC).
Insurance products are offered through LPL or its licensed affiliates. To the extent you are receiving investment advice from a separately registered independent investment advisor that is not an LPL affiliate, please note LPL makes no representation with respect to such entity.
- Not Insured by FDIC/NCUA or Any Other Government Agency
- Not Bank/Credit Union Guaranteed
- Not Bank/Credit Union Deposits or Obligations
- May Lose Value
For Public Use – Tracking 1-05077452